김종국 교수 연구실
article|
인용수 13
·2023
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
Su Yeon Park, Young Nam Kwon, Sun‐Young Kim, Sun‐Young Kim, Seung-Hyun Kim, Seung-Hyun Kim, Jong Kuk Kim, Jun‐Soon Kim, Tai‐Seung Nam, Young Gi Min, Kyung Seok Park, Jin‐Sung Park, Jin Myoung Seok, Jung‐Joon Sung, Eun Hee Sohn, Kyong Jin Shin, Jin‐Hong Shin, Ha Young Shin, Seong‐il Oh, Jeeyoung Oh, Byeol‐A Yoon, Sang-Gon Lee, Jong‐Mok Lee, Hye Lim Lee, Kyomin Choi, So‐Young Huh, Myoung‐jin Jang, Ju‐Hong Min, Byoung Joon Kim, Sung‐Min Kim, Sung‐Min Kim
IF 7.5Journal of Neurology Neurosurgery & Psychiatry
초록
Earlier initiation of rituximab treatment may prevent long-term disability worsening in patients with NMOSD, especially among those with early to middle-age onset, female sex and severe attacks.
키워드
RituximabMedicineNeuromyelitis opticaExpanded Disability Status ScaleInternal medicinePediatricsMultiple sclerosisImmunologyLymphoma